NCT02286687 2026-06-12Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA GenesM.D. Anderson Cancer CenterPhase 2 Active not recruiting150 enrolled